Enzon Pharmaceuticals Inc
DUS:EZ1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enzon Pharmaceuticals Inc
DUS:EZ1
|
US |
|
B
|
Black Swan Graphene Inc
F:R96
|
CA |
|
S
|
Shinsei Bank Ltd
F:LCJ
|
JP |
|
S
|
Suzuki Co Ltd
XBER:SKI
|
JP |
|
N
|
Neogen Corp
F:NG2
|
US |
|
S
|
Singapore Exchange Ltd
OTC:SPXCY
|
SG |
|
Q
|
Quest Pharmatech Inc
OTC:QPTFF
|
CA |
|
Wielton SA
F:2W1
|
PL |
Dividends
Dividend Yield
Enzon Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Enzon Pharmaceuticals Inc
EZ1 have decreased by 0%.
Payout Ratio
Enzon Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
EZ1 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
EZ1 Price
Enzon Pharmaceuticals Inc
| Average Annual Return | -7.99% |
| Standard Deviation of Annual Returns | 48.08% |
| Max Drawdown | -96% |
| Market Capitalization | 59.5m EUR |
| Shares Outstanding | 255 984 530 |
| Percentage of Shares Shorted |
N/A
|